{{Rsnum
|rsid=17570669
|Chromosome=4
|position=110815726
|Orientation=plus
|GMAF=0.03306
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 89.4 | 8.8 | 1.8
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 96.5 | 3.5 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 95.0 | 5.0 | 0.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 96.6 | 3.4 | 0.0
| MKK | 96.2 | 3.8 | 0.0
| TSI | 79.4 | 17.6 | 2.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=20733104
|Title=Independent Susceptibility Markers for Atrial Fibrillation on Chromosome 4q25
|OA=1
}}

{{PMID Auto
|PMID=21760908
|Title=Association between variants on chromosome 4q25, 16q22 and 1q21 and atrial fibrillation in the Polish population
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}